178 related articles for article (PubMed ID: 34267814)
1. Effects of lncRNA ANRIL-knockdown on the proliferation, apoptosis and cell cycle of gastric cancer cells.
Hu X; Lou T; Yuan C; Wang Y; Tu X; Wang Y; Zhang T
Oncol Lett; 2021 Aug; 22(2):621. PubMed ID: 34267814
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ANRIL negatively regulated chitooligosaccharide-induced radiosensitivity in colon cancer cells by sponging miR-181a-5p.
Sun C; Shen C; Zhang Y; Hu C
Adv Clin Exp Med; 2021 Jan; 30(1):55-65. PubMed ID: 33529508
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR‑98 in lung cancer cells.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Oncol Rep; 2020 Sep; 44(3):1025-1036. PubMed ID: 32705261
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-ANRIL inhibits cell senescence of vascular smooth muscle cells by regulating miR-181a/Sirt1.
Tan P; Guo YH; Zhan JK; Long LM; Xu ML; Ye L; Ma XY; Cui XJ; Wang HQ
Biochem Cell Biol; 2019 Oct; 97(5):571-580. PubMed ID: 30789795
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ANRIL promotes proliferation, clonogenicity, invasion and migration of laryngeal squamous cell carcinoma by regulating miR-181a/Snai2 axis.
Hao YR; Zhang DJ; Fu ZM; Guo YY; Guan GF
Regen Ther; 2019 Dec; 11():282-289. PubMed ID: 31667207
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA ANRIL suppresses the production of inflammatory cytokines and mucin 5AC in nasal epithelial cells via the miR-15a-5p/JAK2 axis.
Liu HW; Hu ZL; Li H; Tan QF; Tong J; Zhang YQ
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33325534
[TBL] [Abstract][Full Text] [Related]
7. miR-181a-5p inhibits the proliferation and invasion of drug-resistant glioblastoma cells by targeting F-box protein 11 expression.
Wen X; Li S; Guo M; Liao H; Chen Y; Kuang X; Liao X; Ma L; Li Q
Oncol Lett; 2020 Nov; 20(5):235. PubMed ID: 32968457
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
9. Upregulating the Expression of LncRNA ANRIL Promotes Osteogenesis via the miR-7-5p/IGF-1R Axis in the Inflamed Periodontal Ligament Stem Cells.
Bian M; Yu Y; Li Y; Zhou Z; Wu X; Ye X; Yu J
Front Cell Dev Biol; 2021; 9():604400. PubMed ID: 33692995
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of LncRNA CRNDE aggravates kidney injury via increasing MiR-181a-5p in sepsis.
Wang J; Song J; Li Y; Shao J; Xie Z; Sun K
Int Immunopharmacol; 2020 Feb; 79():105933. PubMed ID: 31877497
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ANRIL promotes HR repair through regulating PARP1 expression by sponging miR-7-5p in lung cancer.
Du Z; Zhang F; Liu L; Shen H; Liu T; Jin J; Yu N; Wan Z; Wang H; Hu X; Chen Y; Cai J
BMC Cancer; 2023 Feb; 23(1):130. PubMed ID: 36755223
[TBL] [Abstract][Full Text] [Related]
12. lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy.
Wang L; Bi R; Li L; Zhou K; Yin H
Aging (Albany NY); 2021 Aug; 13(15):19272-19281. PubMed ID: 34374662
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
Liu Y; Cheng T; Du Y; Hu X; Xia W
BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA-antisense noncoding RNA in the INK4 locus accelerates wound healing in diabetes by promoting lymphangiogenesis via regulating miR-181a/Prox1 axis.
He ZY; Wei TH; Zhang PH; Zhou J; Huang XY
J Cell Physiol; 2019 Apr; 234(4):4627-4640. PubMed ID: 30565672
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis.
Wang K; Hu YB; Zhao Y; Ye C
Onco Targets Ther; 2021; 14():565-576. PubMed ID: 33500630
[TBL] [Abstract][Full Text] [Related]
17. Retracted Article: CircRNA PVT1 modulates cell metastasis
Yan L; Bai M; Xu J; Li X; Wu C; Zhou Y; Yan J; Zhang Z
RSC Adv; 2019 Dec; 9(72):42324-42334. PubMed ID: 35542851
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA Small Nucleolar RNA Host Gene 1 Alleviates Sepsis-Associated Myocardial Injury by Modulating the miR-181a-5p/XIAP Axis
Luo S; Huang X; Liu S; Zhang L; Cai X; Chen B
Ann Clin Lab Sci; 2021 Mar; 51(2):231-240. PubMed ID: 33941563
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
Xu Y; Zheng Y; Duan Y; Ma L; Nan P
Oncol Lett; 2021 May; 21(5):392. PubMed ID: 33777215
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ANRIL promotes NLRP3 inflammasome activation in uric acid nephropathy through miR-122-5p/BRCC3 axis.
Hu J; Wu H; Wang D; Yang Z; Dong J
Biochimie; 2019 Feb; 157():102-110. PubMed ID: 30347231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
